Ampicillin, a broad-spectrum antibiotic from the penicillin group, is considered an essential medicine in India. It is used to treat respiratory tract, throat, and gastrointestinal infections and is effective against a range of gram-positive and some gram-negative bacteria, including certain strains of E. coli and Salmonella.
The prices of ampicillin remained stable throughout Q3'24, with essential medicine prices generally regulated by government authorities to ensure availability and affordability for the public. Recently, the National Pharmaceutical Pricing Authority (NPPA) set prices for 70 essential medicines, including antibiotics, to make them more affordable, particularly for treating common lifestyle diseases like pain, fever, and infections. In the previous quarter, the prices of 41 commonly used medicines were also fixed.
India is working to reduce its dependency on Chinese active pharmaceutical ingredients (APIs) by encouraging domestic production through a production-linked incentive (PLI) scheme. This has supported increased penicillin production, with new manufacturing units dedicated to antibiotic production. Furthermore, with a focus on boosting domestic pharmaceutical manufacturing, India’s antibiotic exports have gained a significant market share in the United States, as per the latest data from the Ministry of Commerce. This has strengthened market confidence, especially as India competes with inexpensive Chinese products in global markets.